Zoetis (ZTS) reported $2.19 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 9.5%. EPS of $1.38 for the same period compares to $1.31 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $2.14 billion, representing a surprise of +2.36%. The company delivered an EPS surprise of +2.99%, with the consensus EPS estimate being $1.34.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

Zoetis (ZTS) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.34 per share. This compares to earnings of $1.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.99%. A quarter ago, it was expected that this animal health company would post earnings of $1.33 per share when it actually produced earnings of $1.24, delivering a surprise of -6.77%.Over the last four quarters, the compa ...

EXHIBIT 99.1 Zoetis Announces First Quarter 2024 Results • Reports Revenue of $2.2 Billion, Growing 10%, and Net Income of $599 Million, or $1.31 per Diluted Share, Increasing 9% and 10%, Respectively, on a Reported Basis for First Quarter 2024 • Delivers 12% Operational Growth in Revenue and 15% Operational Growth in Adjusted Net Income for First Quarter 2024 • Reports Adjusted Net Income of $634 Million, or Adjusted Diluted EPS of $1.38, for First Quarter 2024 • Updates Full Year 2024 Revenue Guidance to ...

Wall Street analysts forecast that Zoetis (ZTS) will report quarterly earnings of $1.35 per share in its upcoming release, pointing to a year-over-year increase of 3.1%. It is anticipated that revenues will amount to $2.14 billion, exhibiting an increase of 7% compared to the year-ago quarter.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their i ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Zoetis (ZTS) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Zoetis currently has an average brok ...

In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day. This change lagged the S&P 500's daily gain of 0.87%. At the same time, the Dow added 0.67%, and the tech-heavy Nasdaq gained 1.11%.Shares of the animal health company have depreciated by 13.26% over the course of the past month, underperforming the Medical sector's loss of 6.67% and the S&P 500's loss of 3.97%.Market participants will be closely following the financial results of Zoetis in its upcomi ...

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zoetis Inc. ("Zoetis" or the "Company") (NYSE:ZTS). The investigation concerns whether Zoetis and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [Click here to learn more about the investigation] On April 12, 2024, Investor's Business Daily published a report on Zoetis which alleged that Zoetis "stock crumbled Fr ...

Justin Paget/DigitalVision via Getty Images Introduction Last year, I started covering Zoetis Inc. (NYSE:ZTS), the animal health-focused healthcare giant. My most recent article on this stock was written on January 10, when I went with the title "Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns." Here's a part of my takeaway back then: Despite economic uncertainties, the company anticipates continued success in key franchises, projecting double-digit operational growth for the companion anima ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Zoetis (ZTS) closed the most recent trading day at $165.69, moving -0.1% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.04%. Meanwhile, the Dow experienced a drop of 0.03%, and the technology-dominated Nasdaq saw an increase of 0.03%.Prior to today's trading, shares of the animal health company had lost 8.95% over the past month. This has lagged the Medical sector's loss of 0.6% and the S&P 500's gain of 2.57% in that time.Market participants will be closel ...